▲ Up
 
08:38 29-07-2015
MAIN АКИpress CA-News
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
British executive accused in China drug bribery

Bishkek (AKIpress) - china-accuses-glaxosmithkline-of-enormous-and-elaborate-bribery-network Chinese police on Wednesday accused a British executive of GlaxoSmithKline of leading a sprawling scheme to bribe doctors and hospitals to use its drugs.

The announcement was the first time a foreign employee in China of British-based GSK was accused in the investigation announced last July. It highlighted the widespread use of payments to doctors and hospitals by sellers of drugs and medical equipment in a poorly funded health system that Chinese leaders have promised to improve, the AP reported.

The executive, Mark Reilly, is accused of operating a "massive bribery network," said a police official, Gao Feng, at a news conference. He said the case had been handed over to prosecutors for formal indictment, the AP said. 

Beginning in January 2009, Reilly is accused of ordering his sales team to pay doctors, hospital officials and health institutions to use GSK's products, said Gao, deputy director of the Ministry of Public Security's economic crimes unit. He said that resulted in "illegal revenue" of billions of yuan (hundreds of millions of dollars).

"GSK's bribery activities ran through its entire operations in China," Gao said.

Gao said Reilly is in China but gave no other details of his status. He said dozens of other people also were implicated but gave no names or other details.

The British Embassy in Beijing said diplomats were in regular contact with Reilly and were providing "consular assistance." The embassy declined to comment further while the case was under way.

Reilly was GSK's senior vice president of pharmaceuticals for China and Hong Kong and former general manager for China.

"We take the allegations that have been raised very seriously. They are deeply concerning to us and contrary to the values of GSK," the company said in a statement. "We want to reach a resolution that will enable the company to continue to make an important contribution to the health and welfare of China and its citizens."

Police previously identified four Chinese employees of GSK who they said confessed to bribery.

A second foreign drugmaker, AstraZeneca, said in July that police in Shanghai were investigating one of its salespeople. The company has given no information since then.

Chinese state media have publicized the bribery investigations of GSK and AstraZeneca. But economists who study Chinese health care say such payments are more widely used by China's domestic drug manufacturers.

Doctors and hospitals routinely accept informal payments from patients and suppliers of medical goods to top up low salaries and cover gaps in budgets.

Hospitals also raise money by adding surcharges to drug prices and assigning employees sales quotas. That can also distort treatment by encouraging overuse of expensive drugs or procedures.

Gao said Reilly used bribery to meet sales targets set by GSK's head office.

The company charged prices up to seven times the level charged in other countries, Gao said. He said that before a patent on one of its drugs was due to expire in 2012, GSK paid bribes to discourage hospitals from switching to cheaper generic versions.

"The more it bribed, the more drugs it could sell," he said.

GSK employees obstructed previous inquiries by bribing investigators and other government officials, Gao said.

In a separate statement, police in the central city of Changsha, where the investigation began, said Reilly and two Chinese executives also are accused of bribing government officials in Beijing and Shanghai.


Twitterfacebookprint
15:44 14.05.2014
LATEST NEWS
17:07 No agreements signed upon arrival of German delegation – government17:03 Funding available for primary construction works of Upper Naryn Cascade HPPs, land allotment still unresolved – RusHydro17:00 150 tons of water spent in Osh daily to water flowers16:45 Police officer hit in head in fight between Kyrgyz, Dungans in Tokmok16:43 Central Bank of Uzbekistan keeps base rate at 9%16:41 Bactamed drug recalled in Kyrgyzstan over 24 cases of damaging nerves of lower extremities16:21 Mongolian president, UN Under-Secretary-General meet in Ulaanbaatar16:18 Roundtable on improvement of public services to be held in Bishkek16:18 Dushanbe hosts meeting of UNESCO Clubs of country16:07 S.Korean doctors provide treatment with calorlpuncture and needle therapy16:01 Over 430 bodies of Tajik citizens delivered from Russia in January-June15:48 Over 2 million tourists from 70 countries annually visit Uzbekistan15:34 Malaysia PM Najib Razak sacks deputy over 1MDB scandal15:26 NATO launches English language training for Uzbek officers15:10 Athlete Suhrob Khodjaev gets ticket to Olympic Games 201615:06 Ala-Buka residents rally against Kazakhmys Gold Kyrgyzstan, say police intimidating14:57 Uzbek government approves general plan of Termez city14:43 Tajik President visits Gorno-Badakhshan Autonomous Region14:40 Prime Minister, central bank chief discuss banking system in Kazakhstan14:34 Kara-Suu district court considering case against ex-imam accused of recruiting Kyrgyz citizens for Syrian hostilities
Astana
+20° C
Ashgabat
+39° C
Bishkek
+33° C
Dushanbe
+32° C
Tashkent
+35° C
exchange rates
 
67.60
61.02
9.83
1.04
207.30
187.25
30.16
3.17
6.85
6.26
1.01
0.12
2710.18
2512.73
405.44
50.01
3.87
3.50
0.56
0.06

© AKIpress News Agency - 2001-2015. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75